Searchlight Pharma Announces Suvexx® Launch in Europe, along with Deal Expansion to all E.U. Markets
- EUR600K upfront payment upon signing the new amendment agreement - - EUR400K payment once launched in significant...
Read MoreSeek. Find. Share.
Searchlight Pharma is a Canadian-based specialty healthcare company dedicated to improving human health and wellness through the acquisition, commercialization, and focused development of unique healthcare products.
Learn More
News & Events
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
• Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with...
Read MoreSol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada
• Sol-Gel to receive up to $11 million in upfront payments and regulatory and sales milestones for both drugs,...
Read More